How will we view schizophrenia in 2030? Schizophrenia today is a chronic, frequently
disabling mental disorder that affects about one per cent of the world's population. After a …

Modeling of human neuropsychiatric disorders in animals is extremely challenging given the
subjective nature of many symptoms, the lack of biomarkers and objective diagnostic tests …

Functional and structural brain imaging has identified neural and neurotransmitter systems
involved in schizophrenia and their link to cognitive and behavioural disturbances such as …

Dopamine D 2 receptor antagonism is a unifying property of all antipsychotic drugs in use for
schizophrenia. While often effective at ameliorating psychosis, these drugs are largely …

Recent years have seen an explosive growth of interest in the application of imaging
genetics to understand neurogenetic mechanisms of schizophrenia. Imaging genetics …

Professor Wolfgang Gaebel is the Medical Director of the Department of Psychiatry and
Psychotherapy of the LVR Klinikum Düsseldorf-Clinics of the Heinrich-Heine University …

Una firma genética para las enfermedades psiquiátricas complejas × Close The Infona portal
uses cookies, ie strings of text saved by a browser on the user's device. The portal can access …